Assembly Biosciences ASMB Enterprise value

Enterprise value at other companies

Arrowhead ResearchARWR

$8.7B+418%

ALN

Alnylam PharmaceuticalsALNY

$38.74B-6.7%

Avalo TherapeuticsAVTX

$886.04M+7,437%

Arbutus Biopharma CorporationABUS

$856.58M+35.5%

Vir Biotechnology, Inc.VIR

$1.52B+191%

Absci CorporationABSI

$1.86B+502%

FAQ

What is Assembly Biosciences's enterprise value?

Assembly Biosciences (ASMB) reported enterprise value of $411.56M in Q1 2026.

How has Assembly Biosciences's enterprise value changed year-over-year?

Assembly Biosciences's enterprise value increased by 701.6% year-over-year, from $51.34M to $411.56M.

What is the long-term trend for Assembly Biosciences's enterprise value?

Over 5 years (2020 to 2025), Assembly Biosciences's enterprise value has grown at a 14.9% compound annual growth rate (CAGR), from $240.25M to $482.12M.

What does enterprise value mean?

Market capitalization plus total debt minus cash, at the quarter end. The cost to acquire the whole business — what an buyer pays for equity and debt, net of the cash they'd inherit.